Skip to main content
SINGULAR HEALTH GROUP LTD logo

SINGULAR HEALTH GROUP LTD — Investor Relations & Filings

Ticker · SHG ISIN · AU0000129892 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 364 across all filing types
Latest filing 2023-09-28 Governance Information
Country AU Australia
Listing ASX SHG

About SINGULAR HEALTH GROUP LTD

https://singular.health/

Singular Health Group Ltd specializes in the development and commercialization of medical imaging software designed to enhance personalized healthcare. The company’s primary offering, the 3Dicom software suite, employs proprietary volume rendering technology to transform standard 2D DICOM files, such as CT and MRI scans, into immersive 3D visualizations. This platform supports surgical planning, remote clinical collaboration, and patient education by providing interactive anatomical models. Singular Health integrates artificial intelligence to automate image segmentation and diagnostic workflows, facilitating more precise clinical outcomes. Through its 'Scan to Surgery' initiative, the company bridges the gap between diagnostic imaging and physical intervention using virtual reality and 3D printing. Its solutions target medical practitioners, dental professionals, and healthcare institutions globally.

Recent filings

Filing Released Lang Actions
Appendix 4G and Corporate Governance Statement 27 pages 650.1KB
Governance Information Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a governance-related disclosure document that serves as a key to where corporate governance disclosures can be found, and it is lodged alongside the annual report. The document explicitly states it is not a substitute for the corporate governance statement but acts as a verification tool for compliance with Listing Rule 4.10.3. The content is focused on governance principles, board charters, diversity policies, and evaluation processes, with references to URLs where detailed governance statements are located. It does not contain financial statements or management discussion of financial results. It is a regulatory filing related to governance disclosures but not the governance report itself. Given the nature and length (15,000 characters) and the detailed governance compliance content, this fits best under Governance Information (CGR).
2023-09-28 English
Appointment of USA Public Affairs & Corporate Advisor 4 pages 169.8KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 20th September 2023 regarding the appointment of a United States Public Affairs & Corporate Advisor for Singular Health Group Ltd. It details the engagement terms of Marin & Sons LLC, including consultancy fees and performance rights subject to shareholder approval at the upcoming Annual General Meeting. The document is a corporate announcement about a strategic appointment and related contractual terms, not a financial report, earnings release, or regulatory filing. It does not contain financial statements or detailed financial analysis. It is not a report publication announcement since it is substantive and not merely stating a report is attached or published. The content fits best under a general regulatory announcement category for corporate updates that do not fit other specific categories.
2023-09-19 English
Proposed issue of securities - SHG 6 pages 29.8KB
Capital/Financing Update Classification · 100% confidence The document is an announcement from Singular Health Group Ltd regarding a proposed issue of new securities (performance rights) as part consideration for services rendered. It includes details about the number of securities, issue price, conditions including shareholder approval at an upcoming AGM, and compliance with ASX listing rules. The document is focused on informing about a capital raising event (placement or other type of issue) and does not contain financial statements or detailed financial performance data. It is not a full report but an update on financing activities. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length and content confirm it is not a brief notice or a regulatory filing fallback.
2023-09-19 English
Preliminary Final Report 35 pages 1.1MB
Annual Report Classification · 95% confidence The document is titled 'Appendix 4E Preliminary Final Report' and is given to the ASX under Listing Rule 4.3A, which is a regulatory requirement for Australian listed companies to provide preliminary final financial information. It includes detailed financial statements such as the Statement of Profit or Loss and Other Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, and Statement of Cash Flows for the year ended 30 June 2023. The document contains comprehensive financial data and analysis for a full fiscal year, including revenue, profit/loss, dividends, and notes to the financial statements. It also references an unaudited financial report attached and mentions that audited financial statements will be released later. This aligns with the characteristics of an Annual Report (10-K equivalent) as it covers the full fiscal year financial performance and position in detail. The document is not a brief announcement or a certification letter, nor is it a regulatory filing or report publication announcement. Therefore, the correct classification is Annual Report (10-K). FY 2023
2023-08-30 English
Strategic Investment from Master Distributor in USA 2 pages 542.7KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 16th August 2023 from Singular Health Group Ltd. It details a strategic investment by CG1 Ventures, including specifics about the share price, number of shares, options, and the purpose of the investment. The content focuses on a capital raise and strategic placement of shares, with no financial statements or detailed financial performance data included. The document is about a financing activity and capital structure update rather than a full financial report or earnings release. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 5181 characters, which is sufficient for a detailed announcement but does not contain comprehensive financial data or management discussion. Hence, the classification is CAP with high confidence.
2023-08-15 English
Proposed issue of securities - SHG 6 pages 32.2KB
Capital/Financing Update Classification · 100% confidence The document is an announcement from Singular Health Group Ltd regarding a proposed issue of securities, including details about the number of securities, issue price, conditions such as shareholder approval, and the purpose of the funds raised. It is structured as a formal notification to the ASX (Australian Securities Exchange) about a placement or other type of securities issue. There are no financial statements, earnings data, or management discussion of results. The content focuses on the capital raising activity and issuance of new shares and options. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and capital structure changes.
2023-08-15 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.